Danos Olivier
SEC CIK 1701180 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | CSO | 226.3K | — | — | 10 | 2021-06-30 | 2025-02-01 |
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Danos Olivier made no open-market trades at RGNX in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-04 | 2025-02-01 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | F - Tax | $8.07 | -5,452 | 226.3K | -2% | -$44.0K | |
| D | 2025-01-06 | 2025-01-02 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | A - Grant | $0.00 | +59.3K | 231.8K | +34% | $0 |
| D | 2025-01-06 | 2025-01-02 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | F - Tax | $7.73 | -12.6K | 172.5K | -7% | -$97.6K |
| M | 2024-08-05 | 2024-06-28+ | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | A - Grant | $0.2252 | +60.2K | 126.2K | +91% | +$13.6K |
| DM | 2024-01-04 | 2022-06-30+ | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | A - Grant | $0.8525 | +40.3K | 124.9K | +48% | +$34.4K |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | F - Tax | $17.95 | -8,410 | 86.4K | -9% | -$151.0K |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | A - Grant | $0.00 | +65.9K | 93.0K | +244% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | F - Tax | $22.68 | -2,058 | 27.0K | -7% | -$46.7K |
| D | 2022-01-04 | 2022-01-01 | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | F - Tax | $32.70 | -1,221 | 18.4K | -6% | -$39.9K |
| DM | 2022-01-04 | 2021-06-30+ | RGNX | REGENXBIO Inc. | Danos Olivier | CSO | A - Grant | $1.63 | +11.3K | 29.1K | +63% | +$18.4K |
Purchase Sale Sale after option exercise All abbreviations